Showing results (1151-1160 of 1,272) with videos related to

Sort By:
Pageof 128
Scientific Reports|June 11, 2016
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulationYavuz Oktay, Ege Ülgen, Özge Can, et al.
Journal of Internal Medicine|September 18, 2023
Circulating markers of extracellular matrix remodelling in severe COVID-19 patientsSarah Louise Murphy, Bente Halvorsen, Jan Cato Holter, et al.
Journal of Clinical Microbiology|May 1, 2020
Practical Comparison of the BioFire FilmArray Pneumonia Panel to Routine Diagnostic Methods and Potential Impact on Antimicrobial Stewardship in Adult Hospitalized Patients with Lower Respiratory Tract InfectionsBlake W Buchan, Sam Windham, Joan-Miquel Balada-Llasat, et al.
Ebiomedicine|October 12, 2025
The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trialCamilla Huse, Sarah Louise Murphy, Kuan Yang, et al.
Immunity|July 28, 2026
Environmentally induced cell stiffening shapes metastatic site selection by tuning the immune vulnerability of cancer cellsYassmin A Elbanna, Maria Tello-Lafoz, Aliya Holland, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Pageof 128